Affinity Asset Advisors, LLC
All holdings · as of Dec 31, 2025
| Company | Value | % of portfolio |
|---|---|---|
| CELCUITY INC | $6.52M | 0.5% |
| ASCENDIS PHARMA A/S | $6.40M | 0.5% |
| Verrica Pharmaceuticals Inc.VRCA | $5.88M | 0.4% |
| enGene Therapeutics Inc. | $5.81M | 0.4% |
| NEWAMSTERDAM PHARMA COMPANY | $5.63M | 0.4% |
| Rezolute, Inc. | $5.55M | 0.4% |
| AVADEL PHARMACEUTICALS PLC | $5.39M | 0.4% |
| Climb Bio, Inc.CLYM | $5.20M | 0.4% |
| Immunovant, Inc.IMVT | $5.08M | 0.4% |
| PROQR THRAPEUTICS N V | $4.96M | 0.4% |
| Dianthus Therapeutics, Inc. | $4.74M | 0.3% |
| ARROWHEAD PHARMACEUTICALS, INC. | $4.65M | 0.3% |
| iBio, Inc.IBIO | $3.97M | 0.3% |
| NextCure, Inc.NXTC | $3.51M | 0.3% |
| Crinetics Pharmaceuticals, Inc. | $3.49M | 0.3% |
| AMGEN INC | $3.27M | 0.2% |
| BELITE BIO, INCBLTE | $3.20M | 0.2% |
| ARRIVENT BIOPHARMA INCAVBP | $3.02M | 0.2% |
| MERSANA THERAPEUTICS INC | $2.89M | 0.2% |
| OAKTREE ACQUISITION CORP III | $2.65M | 0.2% |
| Anteris Technologies Global Corp. | $2.43M | 0.2% |
| Orchestra BioMed Holdings, Inc.OBIO | $2.38M | 0.2% |
| EUPRAXIA PHARMACEUTICALS INC. | $2.27M | 0.2% |
| GERON CORP | $1.98M | 0.1% |
| Ultragenyx Pharmaceutical Inc. | $1.73M | 0.1% |
| KEZAR LIFE SCIENCES INC | $1.44M | 0.1% |
| COMPASS Pathways plcCMPS | $1.38M | 0.1% |
| UNIQURE NV | $1.20M | 0.1% |
| COGENT BIOSCIENCES INC | $1.18M | 0.1% |
| Perspective Therapeutics, Inc. | $825.0K | 0.1% |
| MacroGenics, Inc. | $779.7K | 0.1% |
| Perceptive Capital Solutions Corp | $651.5K | 0.0% |
| X4 Pharmaceuticals, Inc | $580.0K | 0.0% |
| Q32 Bio Inc. | $92.2K | 0.0% |
| Adagio Medical Holdings, Inc. | $83.2K | 0.0% |
| ROCKET PHARMACEUTICALS INC | $1.8K | 0.0% |